Ivar Thokle Hovden

Dr. Ivar Thokle Hovden

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2025 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Open access
QLQinghui Liu
Qinghui Liu
EFElies Fuster-Garcia
Elies Fuster-Garcia
IHIvar Thokle Hovden
Ivar Thokle Hovden
BMBradley J. MacIntosh
Bradley J. MacIntosh
EGEdvard O. S. Grødem
Edvard O. S. Grødem
KEKyrre Emblem
Kyrre Emblem
Diffuse gliomas are malignant brain tumors that grow widespread through the brain. The complex interactions between neoplastic cells and normal tissue, as well as the treatment-induced changes often encountered, make glioma tumor growth modeling challenging. In this paper, we present a novel end-to-end network capable of future predictions of tumor masks and multi-parametric magnetic resonance images (MRI) of how the tumor will look at any future time points for different treatment plans. Our approach is based on cutting-edge diffusion probabilistic models and deep-segmentation neural networks. We included sequential multi-parametric MRI and treatment information as conditioning inputs to guide the generative diffusion process as well as a joint segmentation process. This allows for tumor growth estimates and realistic MRI generation at any given treatment and time point. We trained the model using real-world postoperative longitudinal MRI data with glioma tumor growth trajectories represented as tumor segmentation maps over time. The model demonstrates promising performance across various tasks, including generating high-quality multi-parametric MRI with tumor masks, performing time-series tumor segmentations, and providing uncertainty estimates. Combined with the treatment-aware generated MRI, the tumor growth predictions with uncertainty estimates can provide useful information for clinical decision-making.

28 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
EFElies Fuster-Garcia
Elies Fuster-Garcia
IHIvar Thokle Hovden
Ivar Thokle Hovden
SSSiri Fløgstad Svensson
Siri Fløgstad Svensson
CLChristopher Larsson
Christopher Larsson
JVJonas Vardal
Jonas Vardal
KEKyrre Emblem
Kyrre Emblem
The compression of peritumoral healthy tissue in brain tumor patients is considered a major cause of the life-threatening neurologic symptoms. Although significant deformations caused by the tumor growth can be observed radiologically, the quantification of minor tissue deformations have not been widely investigated. In this study, we propose a method to quantify subtle peritumoral deformations. A total of 127 MRI longitudinal studies from 23 patients with high-grade glioma were included. We estimate longitudinal displacement fields based on a symmetric normalization algorithm and we propose four biomarkers. We assess the interpatient and intrapatient association between proposed biomarkers and the survival based on Cox analyses, and the potential of the biomarkers to stratify patients according to their survival based on Kaplan–Meier analysis. Biomarkers show a significant intrapatient association with survival (p < 0.05); however, only compression biomarkers show the ability to stratify patients between those with higher and lower overall survival (AUC = 0.83, HR = 6.30, p < 0.05 for CompCH). The compression biomarkers present three times higher Hazard Ratios than those representing only displacement. Our study provides a robust and automated method for quantifying and delineating compression in the peritumoral area. Based on the proposed methodology, we found an association between lower compression in the peritumoral area and good prognosis in high-grade glial tumors.

1 November 2020 in European Journal of Radiology
Verified
Journal Article
Open access
IHIvar Thokle Hovden
Ivar Thokle Hovden
OGOliver M. Geier
Oliver M. Geier
IDIngrid Digernes
Ingrid Digernes
EFElies Fuster-Garcia
Elies Fuster-Garcia
GLGrethe Løvland
Grethe Løvland
KEKyrre E. Emblem
Kyrre E. Emblem
Relative cerebral blood volume (rCBV) from dynamic susceptibility contrast (DSC)-MRI is a valuable biomarker in patients with glioblastoma for assessing treatment response and predicting overall survival. DSC-MRI based on echo planar images (EPI) may possess severe geometric distortions from magnetic field inhomogeneities up to the order of centimeters. The aim of this study is to assess how much two readily available EPI-based geometric distortion correction methods, FSL TOPUP and EPIC, affect rCBV values from DSC-MRI in patients with confirmed glioblastoma. We used a combined single-shot 2D gradient-echo (T2*), spin-echo (T2) EPI sequence to estimate both T2* and T2-weighted rCBV from the same contrast agent injection. Effects of distortion correction on the positive phase-encoded T2- and T2*-images were assessed in healthy anatomical brain regions in terms of Wilcoxon signed rank tests on median rCBV change and on Dice coefficients, as well as in tumor lesions in terms of Wilcoxon signed rank tests on median rCBV change. Our results show that following distortion correction, both gradient-echo and spin-echo rCBV increased in cortical areas of the frontal, temporal and occipital lobe, including the posterior orbital gyri in the frontal lobe and middle frontal gyri (p < 0.0008). Similar, improved Dice coefficients were observed for gradient-echo EPI in temporal, occipital and frontal lobe. Only spin-echo rCBV in enhancing lesion increased with correction (p = 0.0002). Our study sheds light on the importance of performing geometric distortion correction on EPI-based MRI data before assessing functional information such as rCBV values. Our findings may indicate that uncorrected rCBV values can be underestimated from positive phase-encoding EPI and that geometric distortion correction is warranted when comparing EPI-based data to conventional MRI.

16 June 2021 in medRxiv
Verified
Preprint
Open access
PDF file
SSSiri Fløgstad Svensson
Siri Fløgstad Svensson
EFElies Fuster-Garcia
Elies Fuster-Garcia
ALAnna Latysheva
Anna Latysheva
JFJorunn Fraser-Green
Jorunn Fraser-Green
WNWibeke Nordhøy
Wibeke Nordhøy
KEKyrre Emblem
Kyrre Emblem
BACKGROUND Understanding how mechanical properties relate to functional changes in glioblastomas may help explain variation between patients. PURPOSE To map differences in biomechanical and functional properties between tumor and healthy tissue, to study their spatial distribution, and to assess any relationship between biomechanical and functional properties. STUDY TYPE Prospective. SUBJECTS Nine patients with glioblastoma, 17 healthy subjects FIELDSTRENGTH/SEQUENCE 3T, MRE, DSC, DTI, ASL ASSESSMENT Stiffness and viscosity measurements G′ and G′′, cerebral blood flow (CBF), apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in patients’ contrast-enhancing tumor, necrosis, edema, and gray and white matter, and in gray and white matter for healthy subjects. STATISTICAL TESTS Voxel-wise regression analysis using a linear and a random forest model for CBF as a function of ADC, FA, G′ and G′′. Model performance was evaluated by root-mean-square error with a leave-one-patient-out cross-validation strategy. A paired Wilcoxon signed-rank test was used for comparisons of different regions and models. A significance level of P<0.05 was assumed for all tests. RESULTS Median G′ and G′′ in contrast-enhancing tumor were 15 % and 39 % lower than in normal-appearing white matter (cNAWM), respectively (P<0.01). FA was 53 % lower in tumor compared to cNAWM (P<0.01). ADC and CBF were 50 % and 2.9 times higher in tumor than in cNAWM, respectively (P<0.01). For both models, prediction of CBF was improved by adding MRE measurements to the model, compared to a baseline model with ADC and FA as predictors (P<0.05). DATA CONCLUSION Tumors differed from healthy tissue with regard to G′ and G′′, CBF, ADC and FA, with heterogeneity both between patients and within tumors. Measurements approached values in normal-appearing tissue when moving outward from the tumor core, but abnormal tissue properties were still present in regions of normal-appearing tissue. The inclusion of MRE measurements in statistical models helped predict perfusion, with stiffer tissue associated with lower perfusion values.